Filter News
Area of Research
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (25)
- Clean Energy (17)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (1)
- Isotopes (7)
- Materials (13)
- Materials for Computing (3)
- National Security (41)
- Neutron Science (15)
- Nuclear Science and Technology (2)
- Supercomputing (34)
News Topics
- (-) Biomedical (61)
- (-) Machine Learning (50)
- (-) National Security (72)
- 3-D Printing/Advanced Manufacturing (128)
- Advanced Reactors (34)
- Artificial Intelligence (101)
- Big Data (60)
- Bioenergy (92)
- Biology (101)
- Biotechnology (24)
- Buildings (67)
- Chemical Sciences (73)
- Clean Water (31)
- Climate Change (105)
- Composites (30)
- Computer Science (198)
- Coronavirus (46)
- Critical Materials (29)
- Cybersecurity (35)
- Decarbonization (85)
- Education (5)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (112)
- Environment (200)
- Exascale Computing (42)
- Fossil Energy (6)
- Frontier (45)
- Fusion (58)
- Grid (66)
- High-Performance Computing (93)
- Hydropower (11)
- Irradiation (3)
- Isotopes (57)
- ITER (7)
- Materials (147)
- Materials Science (146)
- Mathematics (9)
- Mercury (12)
- Microelectronics (4)
- Microscopy (51)
- Molten Salt (9)
- Nanotechnology (60)
- Net Zero (14)
- Neutron Science (137)
- Nuclear Energy (111)
- Partnerships (51)
- Physics (64)
- Polymers (33)
- Quantum Computing (37)
- Quantum Science (72)
- Renewable Energy (2)
- Security (25)
- Simulation (51)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Summit (59)
- Sustainable Energy (130)
- Transformational Challenge Reactor (7)
- Transportation (99)
Media Contacts
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
As Hurricane Dorian raged through the Bahamas, researchers at Oak Ridge National Laboratory worked around the clock to aid recovery efforts for one of the Caribbean’s worst storms ever.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
Jeff Johnson, nonproliferation research and development integration manager for ORNL’s National Security Sciences Directorate, has been honored by the American Nuclear Society
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.